-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, M/hd3LUwRvw9E5FD9nCuPnb2oPfyfGsHi0R6bl/2a+2KoP/t4Xeg6ibIh0lpE5zS pg9y4XAj77J7xT6qBXcvqw== 0001158833-02-000071.txt : 20021106 0001158833-02-000071.hdr.sgml : 20021106 20021106113400 ACCESSION NUMBER: 0001158833-02-000071 CONFORMED SUBMISSION TYPE: SC 13D PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20021106 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: LIFE SCIENCES RESEARCH INC CENTRAL INDEX KEY: 0001158833 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 522340150 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D SEC ACT: 1934 Act SEC FILE NUMBER: 005-62457 FILM NUMBER: 02810658 BUSINESS ADDRESS: STREET 1: PMB #251, 211 EAST LOMBARD STREET CITY: BALTIMORE STATE: MD ZIP: 21202-6102 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: CRAMER KIRBY L CENTRAL INDEX KEY: 0001035505 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SC 13D BUSINESS ADDRESS: STREET 1: METTLERS ROAD CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 MAIL ADDRESS: STREET 1: METTLERS ROAD STREET 2: P. O. BOX 2360 CITY: EAST MILLSTONE STATE: NJ ZIP: 08875 SC 13D 1 sched13dcramer.txt SCHEDULE 13D, KIRBY L. CRAMER SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 SCHEDULE 13D (Rule 13d-101) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULE 13d-1(a) AND AMENDMENTS THERETO FILED PURSUANT TO RULE 13d-2(a) (Amendment No. 1)(1) Life Sciences Research, Inc. - -------------------------------------------------------------------------------- (Name of Issuer) Voting Common Stock, $.01 par value - -------------------------------------------------------------------------------- (Title of Class of Securities) 5321691090 - -------------------------------------------------------------------------------- (CUSIP Number) Kirby L. Cramer c/o Life Sciences Research, Inc. P. O. Box 2360 Mettlers Road East Millstone, NJ 08875 (732) 873-2550 - -------------------------------------------------------------------------------- (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications) November 5, 2002 - -------------------------------------------------------------------------------- (Date of Event which Requires Filing of This Statement) If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(e), 13d-1(f) or 13d-1(g), check the following box [_]. Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7(b) for other parties to whom copies are to be sent. (Continued on following pages) - ---------- (1) The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page. The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). (SC13D-07/99) CUSIP No.5321691090 13D ________________________________________________________________________________ 1 NAME OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY) Kirby L. Cramer ________________________________________________________________________________ 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a) [_] (b) [ ] Not applicable. ________________________________________________________________________________ 3 SEC USE ONLY ________________________________________________________________________________ 4 SOURCE OF FUNDS* Not Applicable ________________________________________________________________________________ 5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) OR 2(e) [_] Not applicable ________________________________________________________________________________ 6 CITIZENSHIP OR PLACE OF ORGANIZATION United States ________________________________________________________________________________ 7 SOLE VOTING POWER 453,007 NUMBER OF SHARES _________________________________________________________________ 8 SHARED VOTING POWER 0 BENEFICIALLY OWNED BY _________________________________________________________________ EACH 9 SOLE DISPOSITIVE POWER 453,007 REPORTING PERSON _________________________________________________________________ 10 SHARED DISPOSITIVE POWER 0 WITH ________________________________________________________________________________ 11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 453,007 ________________________________________________________________________________ 12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* N/A [_] ________________________________________________________________________________ 13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11) 3.8% ________________________________________________________________________________ 14 TYPE OF REPORTING PERSON* IN ________________________________________________________________________________ *SEE INSTRUCTIONS BEFORE FILLING OUT! CUSIP No. 5321691090 13D ________________________________________________________________________________ Item 1. Security and Issuer. Class of Securities: Voting Common Stock, $.01 par value per share (the "Common Stock") Issuer: Life Sciences Research, Inc. (the "Issuer"), P.O. Box 2360, Mettlers Road, East Millstone, NJ 08875 ________________________________________________________________________________ Item 2. Identity and Background. (a) Names: Kirby L. Cramer (b) Business Address: Kirby L. Cramer c/o Life Sciences Research, Inc. P.O. Box 2360, Mettlers Road East Millstone, NJ 08875 (c) Principal Occupation or Employment: Private Investor; director of the Issuer and other public companies. (d) Criminal Convictions: None. (e) Civil Adjudication of Violation of Securities Laws: None. (f) Citizenship: United States citizen. ________________________________________________________________________________ Item 3. Source and Amount of Funds or Other Consideration. N/A ________________________________________________________________________________ Item 4. Purpose of Transaction. (a)-(j) This filing is being made to report the sale by Mr. Cramer of (i) 100,000 shares of the Issuer's Common Stock in a private sale on October 4, 2002 at a sale price of $2.00 per share and (ii) 350,000 shares of the Issuer's Common Stock in a private sale on November 5, 2002 at a sale price of $1.50 per share. ________________________________________________________________________________ Item 5. Interest in Securities of the Issuer. (a) Beneficial Ownership by the Reporting Person: Number of Shares ---------------- Aggregate number of shares: 453,007 Percentage: 3.8% (based on 11,932,338 outstanding shares) (b) Sole Voting Power: 453,007 Shared Voting Power: 0 Sole Dispositive Power: 453,007 Shares Dispositive Power: 0 (c) (i) 100,000 shares of Common Stock of the Issuer were sold in a private sale transaction on October 4, 2002 at a sale price of $2.00 per share. (ii) 350,000 shares of Common Stock of the Issuer were sold in a private sale transaction on November 5, 2002 at a sale price of $1.50 per share. (d) Not applicable. (e) The Reporting Person ceased to be the beneficial owner of more than 5% of the Issuer's Common Stock on November 5, 2002. ________________________________________________________________________________ Item 6. Contracts, Arrangements, Understandings or Relationships with Respect to Securities of the Issuer. N/A ________________________________________________________________________________ Item 7. Material to be Filed as Exhibits. None. ________________________________________________________________________________ SIGNATURE After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. November 6, 2002 ---------------------------------------- (Date) /s/ Kirby Cramer ---------------------------------------- (Signature) Kirby Cramer ---------------------------------------- (Name/Title) Attention. Intentional misstatements or omissions of fact constitute federal criminal violations (see 18 U.S.C. 1001). EDGARLink 7.0 (8/00) Ver. 3.1 -----END PRIVACY-ENHANCED MESSAGE-----